Co-operation between endothelin and nitric oxide in promoting endothelial cell migration and angiogenesis

Michael S. Goligorsky, Adam S. Budzikowski, Hirokazu Tsukahara, Eisei Noiri

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

1. Among the diverse functions of endothelins (ET), their role in the remodelling of blood vessels remains poorly examined. In the present review, we summarize findings obtained in our laboratory and present four independent lines of evidence to support this novel function. We also demonstrate that the motogenic and angiogenic effects of ET are mediated via the ET(B) receptor and that the functional endothelial nitric oxide synthase (NOS) is requisite for this action. 2. We demonstrated that ET stimulates transmigration of endothelial cells in a modified Boyden chamber and accelerates endothelial wound healing acting via ET(B) receptors. 3. In genetically engineered Chinese hamster ovary cells expressing either ET(B) receptor or endothelial NOS or both, application of ET results in accelerated cell migration only when the receptor and the enzyme are coexpressed. Application of antisense oligonucleotides producing a specific knockdown of the endothelial NOS results in the loss of ET ability to stimulate endothelial cell migration in response to ET. 4. Finally, using a novel model of in vivo angiogenesis, we were able to demonstrate that ET enhances formation of new vessels, but this effect requires functional endothelial NOS. 5. The described phenomenon of NO production, serving as a prerequisite for endothelial cell locomotion in response to activation of ET(B) receptor may explain a host of pathophysiological observations on inadequate angiogenesis despite enhanced generation of ET-1. 6. Based on the contribution of endothelial cell migration to angiogenesis, these data may implicate insufficient NO production in pathological states (e.g. atherosclerosis, heart failure and hypertension) in the inappropriate response to angiogenic stimuli.

Original languageEnglish
Pages (from-to)269-271
Number of pages3
JournalClinical and Experimental Pharmacology and Physiology
Volume26
Issue number3
DOIs
Publication statusPublished - 1999
Externally publishedYes

Fingerprint

Endothelins
Cell Movement
Nitric Oxide
Endothelin B Receptors
Endothelial Cells
Nitric Oxide Synthase Type III
Antisense Oligonucleotides
Endothelin-1
Cricetulus
Wound Healing
Blood Vessels
Ovary
Atherosclerosis
Heart Failure
Hypertension
Enzymes

Keywords

  • Angiogenesis
  • Endothelial cell
  • Endothelin
  • Migration
  • Nitric oxide
  • Oligonucleotides

ASJC Scopus subject areas

  • Physiology
  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Co-operation between endothelin and nitric oxide in promoting endothelial cell migration and angiogenesis. / Goligorsky, Michael S.; Budzikowski, Adam S.; Tsukahara, Hirokazu; Noiri, Eisei.

In: Clinical and Experimental Pharmacology and Physiology, Vol. 26, No. 3, 1999, p. 269-271.

Research output: Contribution to journalArticle

@article{7b265d128a894808be069147215b85c1,
title = "Co-operation between endothelin and nitric oxide in promoting endothelial cell migration and angiogenesis",
abstract = "1. Among the diverse functions of endothelins (ET), their role in the remodelling of blood vessels remains poorly examined. In the present review, we summarize findings obtained in our laboratory and present four independent lines of evidence to support this novel function. We also demonstrate that the motogenic and angiogenic effects of ET are mediated via the ET(B) receptor and that the functional endothelial nitric oxide synthase (NOS) is requisite for this action. 2. We demonstrated that ET stimulates transmigration of endothelial cells in a modified Boyden chamber and accelerates endothelial wound healing acting via ET(B) receptors. 3. In genetically engineered Chinese hamster ovary cells expressing either ET(B) receptor or endothelial NOS or both, application of ET results in accelerated cell migration only when the receptor and the enzyme are coexpressed. Application of antisense oligonucleotides producing a specific knockdown of the endothelial NOS results in the loss of ET ability to stimulate endothelial cell migration in response to ET. 4. Finally, using a novel model of in vivo angiogenesis, we were able to demonstrate that ET enhances formation of new vessels, but this effect requires functional endothelial NOS. 5. The described phenomenon of NO production, serving as a prerequisite for endothelial cell locomotion in response to activation of ET(B) receptor may explain a host of pathophysiological observations on inadequate angiogenesis despite enhanced generation of ET-1. 6. Based on the contribution of endothelial cell migration to angiogenesis, these data may implicate insufficient NO production in pathological states (e.g. atherosclerosis, heart failure and hypertension) in the inappropriate response to angiogenic stimuli.",
keywords = "Angiogenesis, Endothelial cell, Endothelin, Migration, Nitric oxide, Oligonucleotides",
author = "Goligorsky, {Michael S.} and Budzikowski, {Adam S.} and Hirokazu Tsukahara and Eisei Noiri",
year = "1999",
doi = "10.1046/j.1440-1681.1999.03029.x",
language = "English",
volume = "26",
pages = "269--271",
journal = "Clinical and Experimental Pharmacology and Physiology",
issn = "0305-1870",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Co-operation between endothelin and nitric oxide in promoting endothelial cell migration and angiogenesis

AU - Goligorsky, Michael S.

AU - Budzikowski, Adam S.

AU - Tsukahara, Hirokazu

AU - Noiri, Eisei

PY - 1999

Y1 - 1999

N2 - 1. Among the diverse functions of endothelins (ET), their role in the remodelling of blood vessels remains poorly examined. In the present review, we summarize findings obtained in our laboratory and present four independent lines of evidence to support this novel function. We also demonstrate that the motogenic and angiogenic effects of ET are mediated via the ET(B) receptor and that the functional endothelial nitric oxide synthase (NOS) is requisite for this action. 2. We demonstrated that ET stimulates transmigration of endothelial cells in a modified Boyden chamber and accelerates endothelial wound healing acting via ET(B) receptors. 3. In genetically engineered Chinese hamster ovary cells expressing either ET(B) receptor or endothelial NOS or both, application of ET results in accelerated cell migration only when the receptor and the enzyme are coexpressed. Application of antisense oligonucleotides producing a specific knockdown of the endothelial NOS results in the loss of ET ability to stimulate endothelial cell migration in response to ET. 4. Finally, using a novel model of in vivo angiogenesis, we were able to demonstrate that ET enhances formation of new vessels, but this effect requires functional endothelial NOS. 5. The described phenomenon of NO production, serving as a prerequisite for endothelial cell locomotion in response to activation of ET(B) receptor may explain a host of pathophysiological observations on inadequate angiogenesis despite enhanced generation of ET-1. 6. Based on the contribution of endothelial cell migration to angiogenesis, these data may implicate insufficient NO production in pathological states (e.g. atherosclerosis, heart failure and hypertension) in the inappropriate response to angiogenic stimuli.

AB - 1. Among the diverse functions of endothelins (ET), their role in the remodelling of blood vessels remains poorly examined. In the present review, we summarize findings obtained in our laboratory and present four independent lines of evidence to support this novel function. We also demonstrate that the motogenic and angiogenic effects of ET are mediated via the ET(B) receptor and that the functional endothelial nitric oxide synthase (NOS) is requisite for this action. 2. We demonstrated that ET stimulates transmigration of endothelial cells in a modified Boyden chamber and accelerates endothelial wound healing acting via ET(B) receptors. 3. In genetically engineered Chinese hamster ovary cells expressing either ET(B) receptor or endothelial NOS or both, application of ET results in accelerated cell migration only when the receptor and the enzyme are coexpressed. Application of antisense oligonucleotides producing a specific knockdown of the endothelial NOS results in the loss of ET ability to stimulate endothelial cell migration in response to ET. 4. Finally, using a novel model of in vivo angiogenesis, we were able to demonstrate that ET enhances formation of new vessels, but this effect requires functional endothelial NOS. 5. The described phenomenon of NO production, serving as a prerequisite for endothelial cell locomotion in response to activation of ET(B) receptor may explain a host of pathophysiological observations on inadequate angiogenesis despite enhanced generation of ET-1. 6. Based on the contribution of endothelial cell migration to angiogenesis, these data may implicate insufficient NO production in pathological states (e.g. atherosclerosis, heart failure and hypertension) in the inappropriate response to angiogenic stimuli.

KW - Angiogenesis

KW - Endothelial cell

KW - Endothelin

KW - Migration

KW - Nitric oxide

KW - Oligonucleotides

UR - http://www.scopus.com/inward/record.url?scp=0032989856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032989856&partnerID=8YFLogxK

U2 - 10.1046/j.1440-1681.1999.03029.x

DO - 10.1046/j.1440-1681.1999.03029.x

M3 - Article

C2 - 10081626

AN - SCOPUS:0032989856

VL - 26

SP - 269

EP - 271

JO - Clinical and Experimental Pharmacology and Physiology

JF - Clinical and Experimental Pharmacology and Physiology

SN - 0305-1870

IS - 3

ER -